|
Volumn 99, Issue 1, 2002, Pages 3-10
|
Response and survival in patients with progressive or recurrent serous ovarian tumors of low malignant potential
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ANTIINFECTIVE AGENT;
ADULT;
ARTICLE;
CANCER CHEMOTHERAPY;
CANCER STAGING;
CONTROLLED STUDY;
DEATH;
DISEASE COURSE;
DISEASE DURATION;
ETHNIC DIFFERENCE;
EVALUATION;
FEMALE;
HUMAN;
MAJOR CLINICAL STUDY;
OVARY TUMOR;
POSTOPERATIVE CARE;
PRIORITY JOURNAL;
PROGNOSIS;
RECURRENCE RISK;
SURVIVAL RATE;
TREATMENT OUTCOME;
ADULT;
AGE DISTRIBUTION;
AGED;
ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS;
BIOPSY, NEEDLE;
CYSTADENOCARCINOMA, SEROUS;
DISEASE PROGRESSION;
DISEASE-FREE SURVIVAL;
FEMALE;
HUMANS;
MIDDLE AGED;
NEOPLASM RECURRENCE, LOCAL;
NEOPLASM STAGING;
OVARIAN NEOPLASMS;
PROBABILITY;
PROGNOSIS;
RETROSPECTIVE STUDIES;
SURVIVAL ANALYSIS;
TREATMENT OUTCOME;
|
EID: 0036149402
PISSN: 00297844
EISSN: None
Source Type: Journal
DOI: 10.1016/S0029-7844(01)01649-0 Document Type: Article |
Times cited : (144)
|
References (33)
|